Black Diamond Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,319
Closed -$210K 121
2023
Q3
$210K Buy
6,319
+438
+7% +$15.5K 0.06% 101
2023
Q2
$216K Sell
5,881
-39
-0.7% -$1.52K 0.06% 100
2023
Q1
$242K Sell
5,920
-61
-1% -$2.63K 0.08% 95
2022
Q4
$306K Hold
5,981
0.11% 81
2022
Q3
$262K Sell
5,981
-181
-3% -$8.79K 0.11% 85
2022
Q2
$323K Sell
6,162
-501
-8% -$25.5K 0.13% 78
2022
Q1
$345K Buy
6,663
+375
+6% +$19.5K 0.11% 82
2021
Q4
$371K Buy
+6,288
New +$312K 0.13% 65
2020
Q2
Sell
-6,625
Closed -$205K 72
2020
Q1
$205K Buy
+6,625
New +$226K 0.16% 64

Other funds holding PFE

Black Diamond Financial's PFE Position: Q4 2023 in Review

Black Diamond Financial sold out of Pfizer (PFE) in Q4 2023, closing a stake of 6,319 shares — an estimated $210K sold.

Black Diamond Financial first reported a position in PFE in Q1 2020 and held it in 9 quarters. The position peaked at $371K in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • Black Diamond Financial reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
  • Black Diamond Financial sold 6,319 Pfizer shares in Q4 2023, an estimated $210K.
  • Black Diamond Financial first reported a position in Pfizer in Q1 2020 and held it in 9 quarters.
  • Black Diamond Financial's Pfizer position peaked at $371K in Q4 2021.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Black Diamond Financial's 13F filing for Q4 2023, filed 12 Feb 2024.